A New Conversational AI SaaS Solution for Cancer Clinical Trial Matching

New solution named ‘Tara’ provides embeddable and scalable patient engagement platform for hospitals, health systems and CROs.

Tara Expands Belong’s Proven Clinical Matching Services to Thousands More Patients.

Belong.Life, a leading global provider of high-engagement patient communities and care platforms, today announced the launch of Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions, following the launch of Dave, the world’s first conversational AI oncology mentor.

Continue Reading >

More Articles

Dave AI – a Revolutionary Tool for Cancer Patients

Promise and Peril of Instant Health Information Access for Consumers. Apps and AI Help Patients…

Dave AI: The Shining Star of TIME’s List 2024

From a pregnancy monitor to a beehive monitor, see which Israeli inventions were chosen for…
Market Leader

Belong.Life Selected: Top Oncology Solution in Healthcare Industry

Belong.Life offers a social network for cancer patients, caregivers, and healthcare professionals. Belong provides patients with personalized content,…
Skip to content